☰

Clinton C. Mason, Ph.D. - Publications

Affiliations: 
2006 Arizona State University, Tempe, AZ, United States 
Area:
Biostatistics Biology, Public Health, Native American Studies
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Reshmi S, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leukemia Research. 56: 44-51. PMID 28193567 DOI: 10.1016/J.Leukres.2017.01.034  0.304
2017 Than H, Pomicter AD, Mason CC, Eiring AM, Heaton WL, Yan D, Senina A, Clair PM, Holyoake TL, O'Hare T, Deininger MW. Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia Blood. 130: 42-42. DOI: 10.1182/Blood.V130.Suppl_1.42.42  0.355
2016 Eiring AM, Khorashad JS, Agarwal A, Mason CC, Bell R, Senina A, Pomicter AD, Yu F, Redwine HM, Bowler AD, Clair PM, Tantravahi SK, McWeeney SK, Druker BJ, Stirewalt DL, et al. MS4A3: A New Player in Leukemic Stem Cell Survival in Chronic Myeloid Leukemia Blood. 128: 934-934. DOI: 10.1182/Blood.V128.22.934.934  0.318
2015 Khorashad JS, Eiring AM, Mason CC, Gantz KC, Bowler AD, Redwine HM, Yu F, Kraft IL, Pomicter AD, Reynolds KR, Iovino AJ, Zabriskie MS, Heaton WL, Tantravahi SK, Kauffman M, et al. shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance. Blood. 125: 1772-81. PMID 25573989 DOI: 10.1182/Blood-2014-08-588855  0.344
2015 Eiring AM, Page BD, Kraft IL, Mason CC, Vellore NA, Resetca D, Zabriskie MS, Zhang TY, Khorashad JS, Engar AJ, Reynolds KR, Anderson DJ, Senina A, Pomicter AD, Arpin CC, et al. Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. Leukemia. 29: 586-97. PMID 25134459 DOI: 10.1038/Leu.2014.245  0.325
2015 Patel SB, Mason CC, Glenn M, Paxton CN, South ST, Cessna MH, Asch JD, Cobain EF, Bixby D, Smith LB, Reshmi SC, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic Analysis of Adult B-ALL Identifies Changes in Copy Number Profile at Relapse and IKZF1/CDKN2A Co-Deletion at Diagnosis As a Marker of Shorter Survival Blood. 126: 1427-1427. DOI: 10.1182/Blood.V126.23.1427.1427  0.316
2015 Eiring AM, Khorashad JS, Agarwal A, Mason CC, Yu F, Redwine HM, Bowler AD, Gantz KC, Reynolds KR, Clair PM, Anderson DJ, Tantravahi SK, McWeeney SK, Druker BJ, Stirewalt DL, et al. MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia Blood. 126: 14-14. DOI: 10.1182/Blood.V126.23.14.14  0.364
2015 Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Schiffman JD, Miles RR. Abstract 1723: IKZF1/CDKN2A co-deletion predicts shorter survival in adult B-ALL Cancer Research. 75: 1723-1723. DOI: 10.1158/1538-7445.Am2015-1723  0.303
2014 Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Pomicter AD, Iovino AJ, Reynolds KR, Eiring AM, Zabriskie MS, Kronenberg Z, Tyner JW, Dalley B, Dao KT, O'Hare T, Yandell M, et al. Next Generation Sequencing to Delineate the Mutational Landscape of Chronic Myelomonocytic Leukemia (CMML): Novel Disease Genes and Correlations with Survival Blood. 124: 4637-4637. DOI: 10.1182/Blood.V124.21.4637.4637  0.32
2014 Eiring AM, Agarwal A, Khorashad JS, Mason CC, Anderson DJ, Yu F, Redwine HM, Gantz KC, Reynolds KR, McWeeney SK, Druker BJ, O'Hare T, Deininger MW. The Tumor Suppressors, MS4A3 and G0S2, Are Downregulated in CML Cells with BCR-ABL1 Kinase-Independent Resistance Blood. 124: 1786-1786. DOI: 10.1182/Blood.V124.21.1786.1786  0.376
2013 Khorashad JS, Kelley TW, Szankasi P, Mason CC, Soverini S, Adrian LT, Eide CA, Zabriskie MS, Lange T, Estrada JC, Pomicter AD, Eiring AM, Kraft IL, Anderson DJ, Gu Z, et al. BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships. Blood. 121: 489-98. PMID 23223358 DOI: 10.1182/Blood-2012-05-431379  0.302
2013 Eiring AM, Kraft IL, Page BD, Zhang TY, Khorashad JS, Vellore NA, Reynolds KR, Pomicter AD, Senina AV, Zabriskie MS, Ahmad S, Mason CC, Moriggl R, Baron R, O'Hare T, et al. BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia Blood. 122: 854-854. DOI: 10.1182/Blood.V122.21.854.854  0.346
2013 Eiring AM, Anderson DJ, Zhang TY, Kraft IL, Reynolds KR, Pomicter AD, Mason CC, O'Hare T, Deininger MW. Direct Contact With Bone Marrow Stromal Cells Protects CML Progenitors From Imatinib Through Cytoplasmic Stabilization Of β-Catenin Blood. 122: 3982-3982. DOI: 10.1182/Blood.V122.21.3982.3982  0.312
2013 Mason CC, Kraft IL, Reynolds KR, Pomicter AD, Eiring AM, Zabriskie MS, Iovino AJ, Heaton W, Tantravahi SK, Kauffman M, Schacham S, Chenchik A, Bonneau K, O'Hare T, Deininger MW. An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia Blood. 122: 2707-2707. DOI: 10.1182/Blood.V122.21.2707.2707  0.334
2013 Colman H, Sato M, Mason CC, Diefes K, Heathcock L, Abegglen L, Aldape K, Schiffman JD. Abstract A08: Chromothripsis and gene-specific copy number aberrations associated with mutation of IDH1 in glioma Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A08  0.321
2012 Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. Plos One. 7: e44424. PMID 22984506 DOI: 10.1371/Journal.Pone.0044424  0.336
2012 Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney International. 82: 1010-7. PMID 22718189 DOI: 10.1038/Ki.2012.234  0.303
2012 Rabin KR, Mason CC, Gurusiddappa S, Leung HE, Morrison DJ, Bhojwani D, Barnette P, South ST, Miles RR, Devidas M, Pession A, Basso G, Potter NE, Kearney L, Moorman AV, et al. IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia Blood. 120: 289-289. DOI: 10.1182/Blood.V120.21.289.289  0.308
2012 Kraft IL, Eiring AM, Page BD, Mason CC, Gu Z, Khorashad JS, Anderson DJ, Pomicter AD, Reynolds KR, Estrada J, Zabriskie MS, Gunning PT, O'Hare T, Deininger MW. Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia. Blood. 120: 2445-2445. DOI: 10.1182/Blood.V120.21.2445.2445  0.344
2011 Williams RC, Muller YL, Hanson RL, Knowler WC, Mason CC, Bian L, Ossowski V, Wiedrich K, Chen YF, Marcovina S, Hahnke J, Nelson RG, Baier LJ, Bogardus C. HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion. Diabetologia. 54: 1684-92. PMID 21484216 DOI: 10.1007/S00125-011-2122-8  0.302
2011 Dabelea D, D'Agostino RB, Mason CC, West N, Hamman RF, Mayer-Davis EJ, Maahs D, Klingensmith G, Knowler WC, Nadeau K. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 54: 78-86. PMID 20886205 DOI: 10.1007/S00125-010-1911-9  0.324
2010 Bian L, Hanson RL, Ossowski V, Wiedrich K, Mason CC, Traurig M, Muller YL, Kobes S, Knowler WC, Baier LJ, Bogardus C. Variants in ASK1 are associated with skeletal muscle ASK1 expression, in vivo insulin resistance, and type 2 diabetes in Pima Indians. Diabetes. 59: 1276-82. PMID 20185809 DOI: 10.2337/Db09-1700  0.354
2009 Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC, Florez JC. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. The Journal of Clinical Endocrinology and Metabolism. 94: 449-55. PMID 19017751 DOI: 10.1210/Jc.2008-1583  0.328
2007 Mason CC, Hanson RL, Knowler WC. Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes. 56: 2054-61. PMID 17473220 DOI: 10.2337/Db07-0053  0.302
2006 Li J, Kuang Y, Mason CC. Modeling the glucose-insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays. Journal of Theoretical Biology. 242: 722-35. PMID 16712872 DOI: 10.1016/J.Jtbi.2006.04.002  0.44
Show low-probability matches.